BofA lowered the firm’s price target on Bunge (BG) to $87 from $105 and keeps a Buy rating on the shares. Q4 adjusted EPS fell short of estimates and the 2025 EPS outlook of about $7.75 was “well-below” the firm’s $9.05 estimate and what BofA believes were investor expectations in the low/mid-$8s, the analyst says. However, post-earnings reset, the firm believes Bunge still offers an attractive risk/reward and the firm has a favorable view of the company’s growth levers, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue